We subsequently demonstrated that ERαS518 is responsible for stimulation of the ERα activity in breast and endometrial cancer cells, as well as for endometrial cancer progression [38], indicating the functional relevance of this phosphorylation site, at least in these malignant cell types. This evidence concerns the gene ERAL1 and endometrial cancer.